GSK-2018682

Lebitso la lik'hemik'hale:

4-(4-(5-(5-chloro-6-isopropoxypyridin-3-yl)-1,2,4-oxadiazol-3-yl)-1H-indol-1-yl) butanoic acid

SMILES Khouto:

O=C(O)CCCN1C=CC2=C1C=CC=C2C3=NOC(C4=CC(Cl)=C(OC(C)C)N=C4)=N3

Khoutu ea InChi:

InChI=1S/C22H21ClN4O4/c1-13(2)30-22-17(23)11-14(12-24-22)21-25-20(26-31-21)16-5-3-6- 18-15(16)8-10-27(18)9-4-7-19(28)29/h3,5-6,8,10-13H,4,7,9H2,1-2H3,(H ,28,29)

InChi Key:

NFIGDBFIDKDNIG-UHFFFAOYSA-N

Keyword:

1034688-30-6;CAS:1034688-30-6;CAS:1034688-30-6;GSK-2018682;GSK 2018682; GSK2018682; 2018682

Sollubility:E qhibiliha ka DMSO

Polokelo:0 - 4 C bakeng sa nako e khutšoanyane (matsatsi ho isa ho libeke), kapa -20 C bakeng sa nako e telele (likhoeli).

Tlhaloso:

GSK2018682 ke agonist bakeng sa li-receptor tsa S1P1 le S1P5.

Sepheo: Agonists bakeng sa ba amohelang S1P1 le S1P5